Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The North America Microarray Market is influenced by a multitude of factors that collectively shape its growth and trajectory. One of the primary drivers is the increasing prevalence of genetic disorders and the growing demand for personalized medicine. As genomic research becomes integral to understanding and treating various diseases, microarray technology plays a pivotal role in analyzing gene expression and genetic variations. The ability of microarrays to simultaneously study thousands of genes makes them crucial tools in genomics and molecular diagnostics, contributing to the expansion of the market.
Research and development activities are paramount in shaping the North America Microarray Market. Ongoing advancements in microarray technology, including the development of high-throughput and cost-effective platforms, drive innovation in the field. Researchers and biotechnology companies continually strive to enhance the sensitivity, accuracy, and versatility of microarrays for various applications, such as cancer research, pharmacogenomics, and infectious disease studies. These innovations contribute to the availability of a diverse range of microarray products, meeting the evolving needs of researchers and clinicians.
Government regulations and healthcare policies significantly impact the North America Microarray Market. Regulatory approvals are essential for the introduction of new microarray platforms and diagnostic applications. Compliance with regulatory standards ensures the reliability and safety of microarray-based tests, instilling confidence among healthcare professionals and researchers. Government policies related to genomic research funding, data privacy, and the integration of genomic technologies into healthcare systems influence market dynamics, affecting the adoption and utilization of microarrays.
The role of healthcare infrastructure and collaboration with research institutions is pivotal in the North America Microarray Market. Well-established healthcare systems and partnerships with academic and research institutions support the integration of microarrays into routine clinical and research practices. Improved infrastructure ensures that the benefits of microarray technology can be effectively translated into clinical applications, contributing to the overall growth of the market.
Market competition is a significant factor driving innovation in the North America Microarray Market. The presence of various biotechnology companies fosters competition, leading to the development of diverse microarray technologies and applications. Companies strive to offer microarrays with improved sensitivity, specificity, and automation features, addressing the evolving needs of research laboratories and healthcare facilities. The competitive landscape encourages continuous improvement in microarray functionalities, benefiting the field of genomics and molecular diagnostics.
Public awareness and the increasing importance of precision medicine contribute to the dynamics of the North America Microarray Market. With a growing emphasis on tailoring medical treatments to individual genetic profiles, both healthcare professionals and the general public are becoming more aware of the potential of microarrays in personalized medicine. Educational initiatives by research institutions, healthcare providers, and industry stakeholders further drive awareness, highlighting the role of microarrays in advancing our understanding of genetic factors in health and disease.
Global economic conditions and research funding patterns influence the North America Microarray Market. Economic factors impact funding for genomics research, market access, and the affordability of microarray technologies. As research budgets vary across institutions and industries, economic considerations play a role in shaping the adoption and utilization of microarrays in different research and clinical settings.
The ongoing COVID-19 pandemic has presented challenges and opportunities for the North America Microarray Market. While the pandemic has diverted resources toward infectious disease research and testing, it has also underscored the importance of molecular diagnostics and genomics in understanding and managing health crises. Microarray technologies that enable comprehensive genomic analysis may find increased relevance in infectious disease studies and surveillance efforts.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 7.3% |
North America Microarray Market Highlights:
North America Microarray Market Overview
North America Microarray Market Size was valued at USD 0.29 Billion in 2023. The North America Microarray industry is projected to grow from USD 0.31 Billion in 2024 to USD 0.55 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.36% during the forecast period (2024 - 2032). North America the market for Microarray is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development.
The AxiomTM PangenomiX Array*, the most ethnically diverse and largest array to date, was introduced by Thermo Fisher Scientific in January 2024. This array provides optimal genetic coverage for pharmacogenomic research and population-scale disease investigations. The majority of the current large-scale genomic datasets, which are utilized for downstream meta-analysis to construct and comprehend disease risk prediction models, are derived from European and Caucasian cohorts. The urgent need for ethnically diverse data sets to generate genetic insights in other populations, such as African, Asian, and increasing mixed populations, is exacerbated by the increasingly diverse and blended global community. Additionally, the healthcare sector is transitioning to a proactive care model, which underscores the significance of conducting research on the influence of genetics on drug response and disease risk. At present, the PangenomiX Array is the sole research solution that integrates four assays into a single test: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood, and HLA typing. The high-throughput array is intended to facilitate the advancement of ancestry and wellness testing, population-scale disease research programs, drug efficacy testing, and drug development research, as well as disease risk and detection research.
In September 2023, Thermo Fisher Scientific introduced a new chromosomal microarray that is intended to enhance the productivity, efficiency, and profitability of cytogenetic research labs. This microarray boasts an industry-leading two-day turnaround time. The Applied Biosystems™ CytoScan™ HD Accel array analyzes the entire human genome and offers enhanced coverage in over 5,000 critical genome regions, providing valuable insights on chromosomal variants for a diverse array of prenatal, postnatal, and oncology research applications. Labs are under pressure to enhance efficacy in order to accommodate the increasing volumes, as there is a persistent shortage of trained laboratory professionals and a growing demand for laboratory services. The CytoScan HD Accel array has the potential to enhance the productivity of assays by up to 100% in laboratories that have an existing apparatus base. The new array also reduces the time required for sample handling and preparation, and it necessitates up to 50% less input sample—as little as 100 ng input DNA—than other commercially available chromosomal microarrays.
Key Finding
- The North America microarray market is expected to reach $0.55 Billion by 2032.
- Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
- U.S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2032.
- Immunohistochemistry segment holds the largest market share of 47.5% in 2015.
North America Microarray Market Segment Insights
North America Microarray Type Insights
North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray.
North America Microarray Product Insights
On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others.
North America Microarray Application
On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.
Regional Analysis
In North America, U.S. is the largest market for Tissue Microarray. Canada is the second-largest market and is expected to be fastest growing market for Tissue Microarray in North America.
Key Players for North America Microarray Market
Some of the key players in this North America Microarray Market are:
- ABCAM,
- ASTERAND BIOSCIENCE,
- IHC WORLD LLC,
- NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE),
- ORIGENE TECHNOLOGIES INC,
- PANTOMICS, INC,
- PROTEIN BIOTECHNOLOGIES INC,
- US BIOMAX, INC.,
- US BIOUPTON INT,
- VITROVIVO BIOTECH, LLC and
- others.
North America Microarray Market by Application
Study objectives of Microarray Market:
- To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Microarray market
- To provide insights about factors affecting the market growth
- To analyze the tattoo removal market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future prospective
- To provide country level analysis of the market for segments by type, by industry and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the North America microarray market.
Intended Audience
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Academic Institutes and Universities
The report for North America Microarray Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
